We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03847376
Brief Title: Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection

First Submitted : February 18, 2019
First Submitted that Met QC Criteria : February 18, 2019
First Posted : February 20, 2019

Last Update Submitted that Met QC Criteria : March 31, 2021
Last Update Posted : April 5, 2021